MYMX Company Profile and Key Details

Q: Who are the executives of MYMX?

Mr. Ronald KempersChief Executive Officer, Chief Operating Officer, Pres & Chief Financial OfficerDr. Sylvain FleuryChief Scientific OfficerDr. Antonius Johanne StegmannHead of R&D and Chief Scientific Officer of Mymetics BVMr. Mario Amacker Ph.D.Head of Quality & Manufacturing

PNK : MYMX

Mymetics

$0.00

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Mymetics Corporation (MYMX) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.

Stock Snapshot

0.0003

Prev. Close

Market Cap

0.0003

Day Low

N/A

P/E Ratio

-40.01053

EPS (TTM)

-0.01

Cash Flow per Share

Open

151.88K

Number of Shares

0.0003

Day High

48.45%

Free Float in %

-0.25

Book Value

100

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 11, 2026	0.00	0.00	0.00	0.00	101
Dec 12, 2025	0.00	0.00	0.00	0.00	143
Oct 14, 2025	0.00	0.00	0.00	0.00	248
Sep 18, 2025	0.00	0.00	0.00	0.00	0
Sep 15, 2025	0.00	0.00	0.00	0.00	0
Sep 11, 2025	0.00	0.00	0.00	0.00	0
Sep 08, 2025	0.00	0.00	0.00	0.00	0
Sep 04, 2025	0.00	0.00	0.00	0.00	0
Sep 02, 2025	0.00	0.00	0.00	0.00	0
Aug 26, 2025	0.00	0.00	0.00	0.00	0
Aug 22, 2025	0.00	0.00	0.00	0.00	100
Aug 15, 2025	0.00	0.00	0.00	0.00	0
Aug 12, 2025	0.00	0.00	0.00	0.00	0
Aug 11, 2025	0.00	0.00	0.00	0.00	0
Aug 08, 2025	0.00	0.00	0.00	0.00	0
Aug 06, 2025	0.00	0.00	0.00	0.00	0
Aug 05, 2025	0.00	0.00	0.00	0.00	0
Aug 04, 2025	0.00	0.00	0.00	0.00	0
Jul 31, 2025	0.00	0.00	0.00	0.00	0
Jul 30, 2025	0.00	0.00	0.00	0.00	0

Contact Details

Epalinges, VD 1066

Switzerland

https://www.mymetics.com 412 165 34535

About Company

Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases. Its robust pipeline features several promising vaccine candidates, including those for HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus (RSV), malaria, and chikungunya. The company actively collaborates with leading institutions such as the Texas Biomedical Research Institute, the PATH Malaria Vaccine Initiative, and the National Institute of Allergy and Infectious Diseases' Laboratory of Malaria Immunology and Vaccinology, focusing on the development and production of virosome-based vaccine formulations for a malaria transmission-blocking agent. Additionally, Mymetics works with Sanofi Pasteur Biologics, LLC to assess the immunogenicity of influenza vaccines. Founded in 1990, the company was formerly known as ICHOR Corporation, adopting its current name in July 2001, and maintains its base of operations in Epalinges, Switzerland.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Company Overview

The stock is currently trading near its 52-week high $0.00 and $0.00. With a market capitalization of about $46.00, Mymetics Corporation is classified as a micro-cap and shows higher-than-market volatility (beta ~2.36). Key stats such as the average daily volume over the past year has been around 90.00 shares, in line with its 52-week average. Headquartered in Epalinges, VD, Mymetics Corporation operates in the Healthcare sector and the Biotechnology industry. Led by CEO Ronald Kempers, the company employs approximately 2 people and listed since October 26, 1999. Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases.

Valuation Metrics

Mymetics Corporation trades at a P/E ratio of -0.02, slightly below the S&P 500 average, with a price-to-sales ratio of 0.01 The P/FCF stands at -0.0, also above market averages.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Financial & Profitability Overview

Over the trailing twelve months, Mymetics generated $3.00K in revenue, or $0.00 per share. Gross margin was -47966.67%, operating margin -58166.67%, and net profit margin -262166.67%. Returns are negative, with ROA at -107.43% and ROE at 12.12%.
On valuation metrics, Mymetics trades at a P/E of -0.02, P/S of 0.01 and P/B of -0.00. Liquidity is tight, with a current ratio of 0.01 and quick ratio of 0.01. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 7489.42 days. Debt-to-equity is -1.11, supported by a cash flow-to-debt ratio of -0.02.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2022, Mymetics posted revenue of $3.00K, down slightly from $3.00K in the prior quarter. Gross profit was - $1.44M (margin -47966.67%). Operating income was - $1.75M (margin -58166.7%). Net income was- $7.87M (EPS - $0.03).
The company ended the quarter with $313.00K in cash and short-term investments, a total debt of $72.00M, and net debt of $71.68M. Total assets were $7.32M, with equity of - $64.90M. Financials further reflected weakness, with operating cash flow of - $1.69M, free cash flow of - $1.69M, and capital expenditures of - $2.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that Mymetics Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Mymetics Corporation trading at a premium to the broader market with a P/E of -0.02.

Frequently Asked Questions

What is the current Mymetics Corporation (MYMX) stock price?

Mymetics Corporation (OTC: MYMX) stock price is $0.00 in the last trading session. During the trading session, MYMX stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in MYMX stock occurred in the recent session was 0% while the dollar amount for the price change in MYMX stock was $0.00.

MYMX's industry and sector of operation?

The OTC listed MYMX is part of Biotechnology industry that operates in the broader Healthcare sector. Mymetics Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MYMX?

Mr. Ronald Kempers
Chief Executive Officer, Chief Operating Officer, Pres & Chief Financial Officer
Dr. Sylvain Fleury
Chief Scientific Officer
Dr. Antonius Johanne Stegmann
Head of R&D and Chief Scientific Officer of Mymetics BV
Mr. Mario Amacker Ph.D.
Head of Quality & Manufacturing

How MYMX did perform over past 52-week?

MYMX's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.00 is -99.62%.

How many employees does MYMX have?

Number of MYMX employees currently stands at 2.

Link for MYMX official website?

Official Website of MYMX is: https://www.mymetics.com

How do I contact MYMX?

MYMX could be contacted at phone 412 165 34535 and can also be accessed through its website. MYMX operates from ROUTE DE LA CORNICHE 4, Epalinges, VD 1066, Switzerland.

How many shares of MYMX are traded daily?

MYMX stock volume for the day was 100 shares. The average number of MYMX shares traded daily for last 3 months was 90.

What is the market cap of MYMX currently?

The market value of MYMX currently stands at $46.00 with its latest stock price at $0.00 and 151.88K of its shares outstanding.

Employees	2
Beta	2.36
Sales or Revenue	$3.00K
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MYMX Company Profile and Key Details

Mymetics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics